Heilongjiang Zbd Pharmaceutical Co., Ltd. is a modern pharmaceutical company located in Harbin, China. The company specializes in the production, sales, and research and development of high-end traditional Chinese medicine formulations. They prioritize the inheritance and innovation of traditional Chinese medicine culture throughout the entire process of drug production and quality management. The company has established a technology innovation platform that involves collaboration with universities and research institutions, actively conducting research on the basic theories of traditional Chinese medicine and cutting-edge scientific and technological advancements both domestically and internationally. Through collaboration with universities and research institutions, they have achieved automated online monitoring during the extraction process of traditional Chinese medicine and automated quality control throughout the entire drug formulation production process. They also utilize advanced monitoring technologies such as traditional Chinese medicine fingerprinting system to ensure the safety, reliability, uniformity, effectiveness, and controllability of drug quality. The company implements a comprehensive risk management mechanism from production to the end market, ensuring that the entire process is controllable and reliable for public medication. To accelerate the perfect integration of traditional medicine and modern science and technology, the company has established a complete pharmaceutical industry chain, including variety research and development, cultivation of traditional Chinese medicinal materials, extraction, formulation production, drug testing, and sales distribution.
Headquarters
No. 8, Yantai 1st Road, Pingfang District, Harbin City, Heilongjiang Province
Harbin; Heilongjiang;
Postal Code: 150060
Contact Details: Purchase the Heilongjiang Zbd Pharmaceutical Co.,Ltd. report to view the information.
Website: http://www.zbdzy.com
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service